Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RICH: Regional Citrate vs Systemic Heparin in CRRT
NCT02669589Phase 4Completed
- Sponsor
- Universitätsklinikum Münster
- Start
- Mar 2016
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of trisodium citrate in acute kidney injury (AKI) (2 arms), sponsored by Universitätsklinikum Münster. Primary endpoints: CRRT-filter life span up to 1 year and Overall Survival at 90 days. Started Mar 2016; status: completed.
02
Drugs
trisodium citrate
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02669589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02669589.